Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE® (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
Home Page | Products | Other Patient Programs | Educational Materials News Media | Contact Us | Privacy Statement | Legal Statement | Links
© 2018 Digestive Care, Inc. All rights reserved. 12016 rev 8 02/2018